Policy on Confidential Information

Background

The Astellas’ business philosophy is to contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. In order to obtain the trust from society and conduct competitive business, the protection of confidential information is essential. Astellas personnel and individuals who act on behalf of Astellas work with confidential information. This policy sets forth global rules and guidelines about how to best protect and prevent the loss of this vital Company asset(s).

Our Position

Confidential information includes information about Astellas medicines and business (including but not limited to trade secrets, financials, intellectual property, research and development), that Astellas has not made available to the general public. Confidential data will exist in multiple formats and may be stored in various ways or methods. Included in confidential data is information lawfully in Astellas’ possession that is owned by third parties.
All Astellas personnel have a responsibility to take the appropriate steps to safeguard confidential information. This includes securely maintaining electronic and hard copy information, putting proper safeguards in place to transfer information, ensuring secure disposal where appropriate, appropriately exchanging information between Astellas entities, and preventing against inadvertent disclosures.

 

Astellas also respects confidential information owned by third parties by not accepting such information unless authorized to do so, and, when authorized, by handling it in accordance with the written agreement governing the information.

 

Updated in November 2023